Enimmune corporation announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 50.706 million compared to TWD 469,000 a year ago. Operating loss was TWD 21.736 million compared to TWD 30.383 million a year ago. Net loss was TWD 13.497 million compared to TWD 28.306 million a year ago. Basic loss per share was TWD 0.22 compared to TWD 0.61 a year ago.